Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)
China flag China · Delayed Price · Currency is CNY
6.24
-0.04 (-0.64%)
Feb 13, 2026, 3:04 PM CST

SHE:002252 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
7,9508,1747,9626,5664,2852,761
Other Revenue
2.852.851.571.323.010.99
7,9538,1767,9646,5674,2882,762
Revenue Growth (YoY)
-4.67%2.67%21.27%53.16%55.26%6.84%
Cost of Revenue
4,9544,8724,7353,6782,0691,059
Gross Profit
3,0003,3043,2292,8892,2191,702
Selling, General & Admin
864867.79712.75706.48616.64528.98
Research & Development
209.7250.9173.74145.71129.02129.69
Other Operating Expenses
76.5248.6531.4932.8123.0520.36
Operating Expenses
1,2051,211912.68900.18756.75682.58
Operating Income
1,7942,0932,3161,9891,4621,020
Interest Expense
-23.5-0.22-0.12-0.26-0.47-0.38
Interest & Investment Income
429.77634.16135.38510.69466.09599.35
Currency Exchange Gain (Loss)
-85.01-85.01-43.34-56.5511.28-9.95
Other Non Operating Income (Expenses)
136.55-0.08-0.42-1.42-1.91-0.69
EBT Excluding Unusual Items
2,2522,6422,4082,4411,9371,608
Impairment of Goodwill
----197.02-361.19-129.68
Gain (Loss) on Sale of Investments
---196.8918.38-42.76-17.58
Gain (Loss) on Sale of Assets
-0.27-1.61-0.010.23-1.350.97
Asset Writedown
-44.05-13.23-4.31-2.47-9.26-2.79
Other Unusual Items
-27.56-7.08-2.5213.1116.5418.35
Pretax Income
2,1802,6202,2042,2741,5391,477
Income Tax Expense
354.57426.31426.65400.61250.09158.64
Earnings From Continuing Operations
1,8262,1941,7771,8731,2891,319
Minority Interest in Earnings
0.63-0.52.047.095.565.12
Net Income
1,8262,1931,7791,8801,2951,324
Net Income to Common
1,8262,1931,7791,8801,2951,324
Net Income Growth
-0.19%23.25%-5.35%45.24%-2.21%117.75%
Shares Outstanding (Basic)
6,6396,6466,5916,7416,7416,403
Shares Outstanding (Diluted)
6,6396,6466,5916,7416,7416,403
Shares Change (YoY)
1.73%0.84%-2.23%-5.28%26.40%
EPS (Basic)
0.280.330.270.280.190.21
EPS (Diluted)
0.280.330.270.280.190.21
EPS Growth
-1.88%22.22%-3.19%46.80%-8.09%72.28%
Free Cash Flow
-598.72-889.21,8271,5001,089917.09
Free Cash Flow Per Share
-0.09-0.130.280.220.160.14
Dividend Per Share
0.0480.0700.0300.0300.0280.025
Dividend Growth
-27.91%133.33%-7.14%12.00%150.00%
Gross Margin
37.72%40.41%40.54%43.99%51.75%61.64%
Operating Margin
22.56%25.60%29.09%30.29%34.10%36.92%
Profit Margin
22.96%26.82%22.34%28.63%30.19%47.93%
Free Cash Flow Margin
-7.53%-10.88%22.94%22.84%25.41%33.21%
EBITDA
2,0232,2932,4772,1691,6161,172
EBITDA Margin
25.44%28.04%31.10%33.03%37.69%42.45%
D&A For EBITDA
228.95199.57160.39180.33154.07152.76
EBIT
1,7942,0932,3161,9891,4621,020
EBIT Margin
22.56%25.60%29.09%30.29%34.10%36.92%
Effective Tax Rate
16.26%16.27%19.36%17.62%16.25%10.74%
Revenue as Reported
7,9538,1767,9646,5674,2882,762
Advertising Expenses
-193.47143.4193.23169.5298.94
Source: S&P Global Market Intelligence. Standard template. Financial Sources.